Global Gout Therapeutics Market Size and Forecast 2023-2032| AbbVie Inc., Sanofi-Aventis, AstraZeneca plc, LG Chem Ltd., GlaxoSmithKline Plc,

The Gout Therapeutics Global Market Report 2023, provides comprehensive information on the gout therapeutics market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Gout Therapeutics Market’s Growth:

https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

The global gout therapeutics market is expected to grow from $2.25 billion in 2022 to $2.54 billion in 2023 at a compound annual growth rate (CAGR) of 12.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The gout therapeutics market is expected to reach $3.96 billion in 2027 at a CAGR of 11.8%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12118&type=smp

Product innovation is the key trend gaining popularity in the gout therapeutics market. Major companies operating in the gout therapeutics market are developing innovative treatments to sustain their position in the market. For instance, in August 2022, Synlogic Inc., a US-based pharmaceutical company, launched SYNB2081, a new drug candidate for gout treatment. The SYNB2081 is a synthetic biotic designed to lower uric acid. It is the second clinical drug candidate developed through a research collaboration between Synlogic and Ginkgo, a US-based biotech company.

The gout therapeutics market is segmented:

1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics

2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication

3) By Disease Condition: Acute, Chronic

4) By End-Users: Hospitals, Specialty Clinics, Other End Users

North America was the largest region in the gout therapeutics market in 2022.

The table of contents in TBRC’s gout therapeutics market report includes

1. Executive Summary

2. Gout Therapeutics Market Characteristics

3. Gout Therapeutics Market Trends And Strategies

4. Gout Therapeutics Market – Macro Economic Scenario

5. Gout Therapeutics Market Segmentation

26. South America Gout Therapeutics Market

27. Brazil Gout Therapeutics Market

28. Middle East Gout Therapeutics Market

29. Africa Gout Therapeutics Market

30. Gout Therapeutics Market Competitive Landscape And Company Profiles

Top Major Players:

AbbVie Inc
Sanofi-Aventis
AstraZeneca plc
LG Chem Ltd
GlaxoSmithKline Plc

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/